The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
← catalyst calendarNCT07612878 · readout in 1,046 d
Sponsored by Sanofi (industry) · SNY — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
350estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-07-31 | estimated | When the study began enrolling |
| Primary completion | 2029-06-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-11-30 | estimated | The whole study's end, after follow-up |
| First posted | 2026-05-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-02 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- COPD (Chronic Obstructive Pulmonary Disease)
Interventions
- Drug: Cohort 1: Dupilumab — also filed as Dupixent
- Other: Cohort 2: usual care only
Primary outcomes
what the primary-completion date above is the date OFParticipant Characteristics
measured End of study (24 months after the last participant is enrolled)
Participant Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Participant Characteristics
measured End of study (24 months after the last participant is enrolled)
Patients Characteristics
measured End of study (24 months after the last participant is enrolled)
Patients Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Patient Characteristics
measured End of study (24 months after the last participant is enrolled)
Permalink · SNY's whole pipeline · Catalyst calendar · Every registered study · What changed